End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,81,000 KRW | +0.77% | -2.62% | +2.76% |
25/04 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
25/04 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SAMSUNG BIOLOGICS CO.,LTD. | Biopharmaceuticals | +0.77% | -2.62% | +2.76% | -.--% | +124.75% | 40.17B |
Technical Rankings Surperformance
- Stock Market
- Equities
- A207940 Stock
- Charts Samsung Biologics Co.,Ltd.
- Comparison Chart